ArticleOncotarget2016

Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers.

Piera Rizzolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.